{"id":"W2956889157","doi":"10.1016/j.pupt.2019.101819","title":"First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis","year":2019,"lang":"en","type":"article","venue":"Pulmonary Pharmacology & Therapeutics","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Inflamax Research (Canada)","funders":"Vertex Pharmaceuticals; North Carolina Biotechnology Center; Cystic Fibrosis Foundation","keywords":"Tolerability; Medicine; Adverse effect; Spirometry; Regimen; Placebo; Vital signs; Clinical trial; Pharmacokinetics; Internal medicine; Pharmacology; Anesthesia; Gastroenterology; Asthma; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002752309,0.001088662,0.002602997,0.0002027836,0.0008285618,0.0008904054,0.0005014402,0.002475097,0.005818191],"category_scores_gemma":[0.002897831,0.000382042,0.001333999,0.0001851738,0.001035902,0.0009571936,0.0004328404,0.00243163,0.001029362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000654741,"about_ca_system_score_gemma":0.001291704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001056815,"about_ca_topic_score_gemma":0.002779209,"domain_scores_codex":[0.9989185,0.0006257414,0.00009007029,0.0001390713,0.00007743876,0.0001492494],"domain_scores_gemma":[0.9979252,0.0006587115,0.0001841294,0.0001768959,0.0002365209,0.0008185841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8262875,0.028296,0.00570762,0.001419824,0.001800008,0.0003047748,0.0003852752,0.0003765048,0.02858492,0.0004473635,0.005278726,0.1011114],"study_design_scores_gemma":[0.3122365,0.6567054,0.016679,0.0002133156,0.00102996,0.0002393302,0.0001854381,0.00033047,0.00437972,0.0003885609,0.007569045,0.00004328289],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9636455,0.01524608,0.001846255,0.003361362,0.001020665,0.005186868,0.002345784,0.0001745157,0.007173001],"genre_scores_gemma":[0.9782456,0.005621881,0.002165518,0.003420312,0.0004998822,0.003313265,0.001908461,0.00002673395,0.004798365],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005818191,"threshold_uncertainty_score":0.01946378,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07496321432924534,"score_gpt":0.417128820108898,"score_spread":0.3421656057796526,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}